Abstract
Estrogen administration to postmenopausal women has been shown to increase plasma levels of apolipoprotein (apo) A-I. A human hepatoma cell line, Hep G2, was used to test the hypothesis that estrogen increases the hepatic production of apo A-I by modulating gene expression. When Hep G2 cells were treated for 24 hours with E2, the apo A-I content in the medium increased 4.3±1.0-fold at 10 μmol/L E2 and 1.8±0.4-fold at 1 μmol/L E2 compared with untreated cells. A time-course experiment indicated that there was no E2-dependent (10 μmol/L) increase in apo A-I medium content at 1 hour and 2 hours and that apo A-I was 165% of controls at 6 hours and 440% at 24 hours. Hep G2 cells were transfected, by the cationic lipid method, with constructs containing serial deletions of the 5' region of the apo A-I gene (-41/+397, -256/+397, and -2500/+397) cloned in front of the luciferase gene and with or without a 7-kb region spanning the apo C-III/A-IV intergenic region, which has been shown to contain regulatory elements for the expression of the apo A-I gene. With the exception of the construct containing only the basal promoter (-41/+ 397), the expression of all constructs was 2- to 3-fold greater in the presence of E2. The smallest construct that maintained E2 responsiveness, the -256/+397 construct, does not contain a typical estrogen-responsive element. In the same transfection experiments, the 4-fold increase in apo A-I in the culture medium was preserved. However, when the same set of transfections was performed by the calcium phosphate precipitation method, the E2 effect on the apo A-I content in the culture medium and on transcription activation was nearly abolished. This effect was probably mediated by Ca2+, because incubation of cells with 20 mmol/L CaCl2 abolished the E2 response. In conclusion, E2 increases apo A-I production in hepatic cells by increasing the transcription of the apo A- I gene.
Author supplied keywords
Cite
CITATION STYLE
Lamon-Fava, S., Ordovas, J. M., & Schaefer, E. J. (1999). Estrogen increases apolipoprotein (Apo) A-I secretion in Hep G2 cells by modulating transcription of the apo A-I gene promoter. Arteriosclerosis, Thrombosis, and Vascular Biology, 19(12), 2960–2965. https://doi.org/10.1161/01.ATV.19.12.2960
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.